Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Corvus Pharmaceuticals, Inc. Director's Dealing 2024

Feb 8, 2024

32755_dirs_2024-02-08_f3eb19e1-532b-4ee9-b60f-fb23b07f5208.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2024-02-02

Reporting Person: Arcara Jeffrey (N/A)

More from Corvus Pharmaceuticals, Inc.

Regulatory Filings 2026
May 14
Share Issue/Capital Change 2026
May 7
Major Shareholding Notification 2026
Mar 26
Major Shareholding Notification 2026
Feb 5
Major Shareholding Notification 2026
Jan 30
Director's Dealing 2026
Jan 30
Major Shareholding Notification 2026
Jan 27
Capital/Financing Update 2026
Jan 23
Capital/Financing Update 2026
Jan 23
Capital/Financing Update 2026
Jan 20
View all filings →